Show simple item record

dc.contributor.authorMuranushi, C
dc.contributor.authorOlsen, C
dc.contributor.authorGreen, Adèle C
dc.contributor.authorPandeya, N
dc.date.accessioned2015-12-10T09:39:27Zen
dc.date.available2015-12-10T09:39:27Zen
dc.date.issued2015-09-30en
dc.identifier.citationCan oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis. 2015: J Am Acad Dermatolen
dc.identifier.issn1097-6787en
dc.identifier.pmid26433247en
dc.identifier.doi10.1016/j.jaad.2015.08.034en
dc.identifier.urihttp://hdl.handle.net/10541/583562en
dc.description.abstractEvidence for an association between aspirin or other nonsteroidal antiinflammatory drug (NSAID) use and basal cell carcinoma (BCC) has been inconsistent.
dc.languageENGen
dc.language.isoenen
dc.rightsArchived with thanks to Journal of the American Academy of Dermatologyen
dc.titleCan oral nonsteroidal antiinflammatory drugs play a role in the prevention of basal cell carcinoma? A systematic review and metaanalysis.en
dc.typeArticleen
dc.contributor.departmentSchool of Population Health, University of Queensland, Brisbane, Australiaen
dc.identifier.journalJournal of the American Academy of Dermatologyen
html.description.abstractEvidence for an association between aspirin or other nonsteroidal antiinflammatory drug (NSAID) use and basal cell carcinoma (BCC) has been inconsistent.


Files in this item

This item appears in the following Collection(s)

Show simple item record